跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20,141 条关于
“anti-CD40”
全部
20,141
临床试验
10,303
药物
3,886
机构
78
资讯
5,874
去年
CD40 and CD70 Targeted Therapies Show Promise in Clinical Trials for Cancer and Autoimmune Diseases
去年
Frexalimab Shows Promise in Treating Autoimmune Diseases by Targeting CD40 Ligand
11个月前
Tonix Pharmaceuticals Advances TNX-1500 Anti-CD40L Antibody for Transplant Rejection Prevention
2年前
Eledon's Tegoprubart Shows Superior Kidney Function Preservation in Phase 1b Transplant Trial
8个月前
Eledon's Tegoprubart Shows Promise in Phase 2 Kidney Transplant Trial, Advances to Phase 3 Development
11个月前
CD40-Targeted Therapies Advance Toward First Approval by 2027 with Over 35 Candidates in Clinical Development
去年
Tegoprubart Successfully Used in Second Pig-to-Human Kidney Xenotransplant at MGH
去年
TNX-1500 Shows Promising Safety Profile in Phase I Trial for Transplant Recipients
去年
BI655064 Shows Promise in Improving Renal Outcomes in Lupus Nephritis
上个月
Spero Therapeutics Appoints Dr. Debra Jeske Zack as CMO to Lead Phase 2-Ready Anti-CD40L Antibody SP001
第 1 页,共 588 页
上一页
下一页